Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Leucoreduction of blood components: an effective way to increase blood safety?

Literature DB >> 26710353

Leucoreduction of blood components: an effective way to increase blood safety?

Maria Bianchi^1,2, Stefania Vaglio^1,3, Simonetta Pupella¹, Giuseppe Marano¹, Giuseppina Facco^1,4, Giancarlo M Liumbruno¹, Giuliano Grazzini¹.

Abstract

Over the past 30 years, it has been demonstrated that removal of white blood cells from blood components is effective in preventing some adverse reactions such as febrile non-haemolytic transfusion reactions, immunisation against human leucocyte antigens and human platelet antigens, and transmission of cytomegalovirus. In this review we discuss indications for leucoreduction and classify them into three categories: evidence-based indications for which the clinical efficacy is proven, indications based on the analysis of observational clinical studies with very consistent results and indications for which the clinical efficacy is partial or unproven.

Entities: Species

Mesh：

Substances：
HLA Antigens

Year: 2015 PMID： 26710353 PMCID： PMC4918553 DOI： 10.2450/2015.0154-15

Source DB: PubMed Journal: Blood Transfus ISSN： 1723-2007 Impact factor: 3.443

132 in total

1. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.

Authors: Matthew D Seftel; Gershon H Growe; Tanya Petraszko; W Barrett Benny; Alan Le; Chao-Yong Lee; John J Spinelli; Heather J Sutherland; Peter Tsang; Donna E Hogge
Journal: Blood Date: 2003-09-04 Impact factor: 22.113

Review 2. Clinical effects of leucoreduction of blood transfusions.

Authors: Y M Bilgin; L M G van de Watering; A Brand
Journal: Neth J Med Date: 2011-10 Impact factor: 1.422

3. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.

Authors: Malte Ziemann; Sabine Krueger; Andrea B Maier; Alexander Unmack; Siegfried Goerg; Holger Hennig
Journal: Transfusion Date: 2007-11 Impact factor: 3.157

4. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.

Authors: Rachel R Wang; Darrell J Triulzi; Lirong Qu
Journal: Am J Clin Pathol Date: 2012-08 Impact factor: 2.493

5. Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.

Authors: Cassandra D Josephson; Marta-Inés Castillejo; Angela M Caliendo; Edmund K Waller; James Zimring; Kirk A Easley; Michael Kutner; Christopher D Hillyer; John D Roback
Journal: Transfus Med Rev Date: 2011-02-23

6. Transfusion-transmitted CMV infections. Clinical importance and means of prevention?

Authors:
Journal: Vox Sang Date: 1984 Impact factor: 2.144

Review 7. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review.

Authors: Shelley R Salpeter; Jacob S Buckley; Saurav Chatterjee
Journal: Am J Med Date: 2013-10-07 Impact factor: 4.965

8. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.

Authors: Neil Blumberg; Joanna M Heal; Kelly F Gettings; Richard P Phipps; Debra Masel; Majed A Refaai; Scott A Kirkley; L Benjamin Fialkow
Journal: Transfusion Date: 2010-12 Impact factor: 3.157

9. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.

Authors: K Oksanen; R Kekomäki; T Ruutu; S Koskimies; G Myllylä
Journal: Transfusion Date: 1991-09 Impact factor: 3.157

10. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study.

Authors: Alexander P J Vlaar; Jan M Binnekade; David Prins; Danielle van Stein; Jorrit J Hofstra; Marcus J Schultz; Nicole P Juffermans
Journal: Crit Care Med Date: 2010-03 Impact factor: 7.598

14 in total

1. Leucoreduction of blood components: clinical and molecular evidence.

Authors: Angelo D'alessandro
Journal: Blood Transfus Date: 2015-12-16 Impact factor: 3.443

Review 2. The accumulation of lipids and proteins during red blood cell storage: the roles of leucoreduction and experimental filtration.

Authors: Christopher C Silliman; Timothy Burke; Marguerite R Kelher
Journal: Blood Transfus Date: 2017-03 Impact factor: 3.443

3. Platelet-, leucocyte- and red cell-derived microparticles in stored whole blood, with and without leucofiltration, with and without ionising radiation.

Authors: Shunnichi Saito; Kenneth E Nollet; Alain M Ngoma; Takako Ono; Hitoshi Ohto
Journal: Blood Transfus Date: 2016-11-07 Impact factor: 3.443

4. Plasma Transfusion Products and Contamination with Cellular and Associated Pro-Inflammatory Debris.

Authors: Yong B Tan; Richard R Rieske; Jon P Audia; Viktor M Pastukh; Gina C Capley; Mark N Gillespie; Alison A Smith; Danielle M Tatum; Juan C Duchesne; Matt E Kutcher; Jeffrey D Kerby; Jon D Simmons
Journal: J Am Coll Surg Date: 2019-04-25 Impact factor: 6.113

5. A Novel Centrifugation Method Using a Cell Salvage Device Offers an Alternative to the Use of Leukocyte-Depleting Filters for Autologous Blood Transfusions.

Authors: Michael Barchilon; Cristina Gaspar; Angela Mexas; Don Nieter
Journal: J Extra Corpor Technol Date: 2016-12

10. A Comparative Study of the Effect of Leukoreduction and Pre-storage Leukodepletion on Red Blood Cells during Storage.

Authors: Thelma A Pertinhez; Emanuela Casali; Fabio Baroni; Pamela Berni; Roberto Baricchi; Alberto Spisni
Journal: Front Mol Biosci Date: 2016-04-21